Best of SABCS® 2024 Eli Lilly Lunch Symposium: Advancements in the use of CDK 4/6 inhibitors in Earlyand Metastatic Breast Cancer Management – Dr. David Cescon, Dr. Stephen Chia, Dr. Erin Powell & Dr. Christine Brezden-Masley

Now that you have watched the video, has your opinion on the following question changed?

Icon Chair Speaker

Chair

Dr. Christine Brezden-Masley
Dr. David Cescon

Icon Chair Speaker

Speakers

Dr. David Cescon
Dr. Stephen Chia
Dr. Erin Powell
Dr. Christine Brezden-Masley

This program has been made possible through unrestricted support from Eli Lilly